ATE350467T1 - Rekombinantes herpesvirus aus trufhähnen und seine verwendungen - Google Patents
Rekombinantes herpesvirus aus trufhähnen und seine verwendungenInfo
- Publication number
- ATE350467T1 ATE350467T1 AT95930814T AT95930814T ATE350467T1 AT E350467 T1 ATE350467 T1 AT E350467T1 AT 95930814 T AT95930814 T AT 95930814T AT 95930814 T AT95930814 T AT 95930814T AT E350467 T1 ATE350467 T1 AT E350467T1
- Authority
- AT
- Austria
- Prior art keywords
- turkeys
- herpesvirus
- provides
- truff
- cocks
- Prior art date
Links
- 241001529453 unidentified herpesvirus Species 0.000 title abstract 2
- 241001502481 Meleagrid alphaherpesvirus 1 Species 0.000 abstract 5
- 102000004127 Cytokines Human genes 0.000 abstract 2
- 108090000695 Cytokines Proteins 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
- 230000003612 virological effect Effects 0.000 abstract 2
- 241000701047 Gallid alphaherpesvirus 2 Species 0.000 abstract 1
- 208000006758 Marek Disease Diseases 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 238000003780 insertion Methods 0.000 abstract 1
- 230000037431 insertion Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16341—Use of virus, viral particle or viral elements as a vector
- C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/288,065 US5961982A (en) | 1985-09-06 | 1994-08-09 | Recombinant herpesvirus of turkeys and uses thereof |
US08/362,240 US5965138A (en) | 1985-09-06 | 1994-12-22 | Recombinant chimeric virus and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE350467T1 true ATE350467T1 (de) | 2007-01-15 |
Family
ID=26964815
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95930814T ATE350467T1 (de) | 1994-08-09 | 1995-08-09 | Rekombinantes herpesvirus aus trufhähnen und seine verwendungen |
AT06026820T ATE498006T1 (de) | 1994-08-09 | 1995-08-09 | Rekombinantes herpesvirus aus truthähnen und seine verwendungen |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06026820T ATE498006T1 (de) | 1994-08-09 | 1995-08-09 | Rekombinantes herpesvirus aus truthähnen und seine verwendungen |
Country Status (11)
Country | Link |
---|---|
US (1) | US5965138A (de) |
EP (2) | EP1801204B1 (de) |
JP (2) | JP3756950B2 (de) |
AT (2) | ATE350467T1 (de) |
AU (1) | AU711815C (de) |
CA (1) | CA2196570C (de) |
DE (2) | DE69535359T2 (de) |
DK (1) | DK0776361T3 (de) |
ES (1) | ES2278382T3 (de) |
MX (1) | MX9700833A (de) |
WO (1) | WO1996005291A1 (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0748631B1 (de) * | 1988-09-13 | 2006-02-08 | Mérial | Virale Vakzine |
US6913751B2 (en) * | 1992-06-12 | 2005-07-05 | Schering-Plough Veterinary Corporation | Recombinant avian herpesvirus useful in vaccine production |
US6183753B1 (en) * | 1994-08-09 | 2001-02-06 | Schering-Plough Veterinary Corp. | Recombinant chimeric virus and uses thereof |
US6984728B2 (en) | 1993-09-24 | 2006-01-10 | Schering Corporation | Recombinant infectious laryngotracheitis virus and uses thereof |
FR2728795B1 (fr) * | 1994-12-30 | 1997-03-21 | Rhone Merieux | Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire |
FR2728794B1 (fr) * | 1994-12-30 | 1997-03-21 | Rhone Merieux | Vaccin recombinant aviaire a base de virus herpes aviaire, notamment contre la maladie de gumboro |
US6632664B1 (en) | 1997-10-03 | 2003-10-14 | Nippon Zeon Co., Ltd. | Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same |
US6506385B1 (en) | 1998-04-17 | 2003-01-14 | Embrex, Inc. | Live vaccines and methods of treatment therewith |
US6299882B1 (en) | 1999-04-09 | 2001-10-09 | Schering Corporation | UL54.5 of Marek's disease virus (MDV) |
CA2388822A1 (en) * | 1999-10-29 | 2001-05-10 | Human Genome Sciences, Inc. | 27 human secreted proteins |
US6516246B2 (en) * | 2000-09-11 | 2003-02-04 | Mimicking Man Manually, Inc. | Method and system for determining native neurological dominant hemisphere |
US7314715B2 (en) * | 2001-06-14 | 2008-01-01 | Schering-Plough Animal Health Corporation | Recombinant avian herpesvirus useful in vaccine production |
US6764684B2 (en) | 2001-09-28 | 2004-07-20 | Zeon Corporation | Avian herpesvirus-based recombinant infectious bursal disease vaccine |
WO2003100007A2 (en) | 2002-05-24 | 2003-12-04 | Schering-Plough Ltd. | Eta-1 gene and methods for use |
JP2007511216A (ja) | 2003-11-17 | 2007-05-10 | クルセイド ラボラトリーズ リミテッド | 変異ウイルス |
GB0326798D0 (en) | 2003-11-17 | 2003-12-24 | Crusade Lab Ltd | Methods for generating mutant virus |
US7897146B2 (en) | 2003-11-17 | 2011-03-01 | Crusade Laboratories Limited | Treatment using herpes simplex virus |
ES2388548T3 (es) * | 2005-04-08 | 2012-10-16 | Bayer Cropscience Nv | Suceso de élite A2704-12 y métodos y estuches para identificar a dicho suceso en muestras biológicas |
US20080241188A1 (en) * | 2007-03-30 | 2008-10-02 | Zeon Corporation | Turkey herpesvirus vectored recombinant containing avian influenza genes |
JP2011525519A (ja) * | 2008-06-23 | 2011-09-22 | インターベツト・インターナシヨナル・ベー・ベー | インターロイキン12をコードするシチメンチョウの組換えヘルペスウイルス |
US9089360B2 (en) | 2008-08-06 | 2015-07-28 | Ethicon Endo-Surgery, Inc. | Devices and techniques for cutting and coagulating tissue |
EP2768529A1 (de) * | 2011-10-21 | 2014-08-27 | Intervet International B.V. | Rekombinanter nichtpathogener mdv-vektor für multivalente immunität |
BR112014009565A2 (pt) * | 2011-10-21 | 2017-04-18 | Intervet Int Bv | vírus da doença de marek não patogênico recombinante, ácido nucleico recombinante, vacina, e, método para ajudar na proteção de um frango contra vírus |
EP2644702A1 (de) | 2012-03-30 | 2013-10-02 | Ceva Sante Animale | Multivalentes rekombinantes Vogelherpesvirus und Impfstoff zur Immunisierung von Vogelarten |
AR097029A1 (es) * | 2013-07-26 | 2016-02-17 | Intervet Int Bv | Aceleración de la respuesta inmune inducida por virus vectorial en aves, composición, uso, método para la vacunación y método para acelerar la respuesta inmune |
AR103245A1 (es) | 2014-12-24 | 2017-04-26 | Intervet Int Bv | Vacuna vectorial basada en hvt (herpes virus de los pavos) frente a nd (enfermedad de newcastle) - ibd (enfermedad de gumboro) mejorada |
US11596687B2 (en) | 2016-06-17 | 2023-03-07 | Intervet Inc. | Recombinant non-pathogenic Marek's disease virus constructs encoding infectious laryngotracheitis virus and infectious bursal disease virus antigens |
KR102617503B1 (ko) * | 2016-12-14 | 2023-12-29 | 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 | 조류 병원체의 다중 항원을 발현하는 재조합 hvt 벡터 및 그를 포함하는 백신 |
BR112020007213A2 (pt) | 2017-10-12 | 2020-10-13 | Intervet International B.V. | construtos de vírus da doença de marek não patogênico recombinante que codificam múltiplos antígenos heterólogos |
CA3153379A1 (en) | 2019-09-11 | 2021-03-18 | Zoetis Services Llc | Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof |
US20230031097A1 (en) | 2019-12-20 | 2023-02-02 | Intervet Inc. | Multivalent hvt vector vaccine |
IL299033A (en) | 2020-06-17 | 2023-02-01 | Boehringer Ingelheim Vetmedica Gmbh | Recombinant HVT vectors expressing influenza hemagglutinin and immunogenic compounds, production and uses thereof |
EP4267179A1 (de) | 2020-12-24 | 2023-11-01 | Intervet International B.V. | Multivalenter hvt-vektorimpfstoff |
WO2023213946A1 (en) | 2022-05-05 | 2023-11-09 | Intervet International B.V. | New multivalent hvt vector vaccine |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4859587A (en) * | 1984-06-04 | 1989-08-22 | Institut Merieux | Recombinant herpes simplex viruses, vaccines and methods |
US5928648A (en) | 1985-09-06 | 1999-07-27 | Syntro Corporation | Recombinant herpesvirus of turkeys and uses thereof |
US4877737A (en) * | 1985-09-06 | 1989-10-31 | Prutech Research And Development Partnership | Attenuated pseudorabies virus which has a deletion in at least a portion of a repeat sequence and vaccine containing same |
US5047237A (en) * | 1985-09-06 | 1991-09-10 | Prutech Research And Development Partnership | Attenuated pseudorabies virus having a deletion of at least a portion of a gene encoding an antigenic, nonessential protein, vaccine containing same and methods of identifying animals vaccinated with the vaccine |
US5223424A (en) * | 1985-09-06 | 1993-06-29 | Prutech Research And Development | Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence |
JPH02502693A (ja) * | 1987-03-19 | 1990-08-30 | サイナーゲン,インコーポレーテッド | 外来dna発現産物の家禽類への導入のためのウイルスベクター系およびその作製方法 |
EP0658623A3 (de) * | 1987-07-27 | 1995-09-27 | Syntro Corp | Attenuierte Herpesviren, Herpesvirein, die eine Aminosäuresequenz kodierende fremde DNS beeinhalten, und sie enthaltende Impstoffe. |
JP2583115B2 (ja) * | 1988-09-10 | 1997-02-19 | 財団法人化学及血清療法研究所 | 組換えマレック病ウイルスおよびその製法 |
EP0748631B1 (de) * | 1988-09-13 | 2006-02-08 | Mérial | Virale Vakzine |
US5225336A (en) * | 1989-03-08 | 1993-07-06 | Health Research Incorporated | Recombinant poxvirus host range selection system |
ES2070997T3 (es) * | 1989-12-04 | 1995-06-16 | Akzo Nobel Nv | Virus de herpes recombinante de pavos y vacunas vector vivas derivadas de los mismos. |
FR2659349B1 (fr) * | 1990-03-12 | 1993-12-24 | Rhone Merieux | Virus herpes recombinants notamment pour la realisation de vaccins, leur procede de preparation, les plasmides realises au cours de ce procede et les vaccins obtenus. |
EP0473210B1 (de) * | 1990-07-30 | 1994-04-13 | Akzo Nobel N.V. | Rekombinantes Mareks-Krankheitsvirus |
US5252717A (en) * | 1990-08-24 | 1993-10-12 | Board Of Trustees Operating Michigan State University | Marek's disease herpesvirus DNA segments encoding glycoproteins, gD, gI and gE |
WO1992003554A1 (en) * | 1990-08-24 | 1992-03-05 | Arthur Webster Pty. Ltd. | Infectious laryngotracheitis virus vaccine |
FR2666589B1 (fr) * | 1990-09-07 | 1994-08-05 | Rhone Merieux | Nouveaux virus herpes recombinants, vaccin a base de ces recombinants, leur procede de preparation, genes, vecteurs et plasmides utilises dans ce procede. |
EP0486106A3 (en) * | 1990-11-16 | 1992-12-23 | Akzo N.V. | Marek's disease virus vaccine |
US5240703A (en) * | 1991-03-01 | 1993-08-31 | Syntro Corporation | Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof |
KR100242671B1 (ko) * | 1991-03-07 | 2000-03-02 | 고돈 에릭 | 유전학적으로 처리한 백신 균주 |
US5853733A (en) * | 1993-02-26 | 1998-12-29 | Syntro Corporation | Recombinant herpesvirus of turkeys and uses thereof |
FR2697534A1 (fr) * | 1992-11-02 | 1994-05-06 | Rhone Merieux | Virus herpès de la dinde recombinant pour la réalisation de vaccin de la maladie de Gumboro, son procédé de préparation et vaccin obtenu. |
-
1994
- 1994-12-22 US US08/362,240 patent/US5965138A/en not_active Expired - Lifetime
-
1995
- 1995-08-09 AU AU34053/95A patent/AU711815C/en not_active Expired
- 1995-08-09 DK DK95930814T patent/DK0776361T3/da active
- 1995-08-09 DE DE69535359T patent/DE69535359T2/de not_active Expired - Lifetime
- 1995-08-09 AT AT95930814T patent/ATE350467T1/de not_active IP Right Cessation
- 1995-08-09 ES ES95930814T patent/ES2278382T3/es not_active Expired - Lifetime
- 1995-08-09 DE DE69536138T patent/DE69536138D1/de not_active Expired - Lifetime
- 1995-08-09 JP JP50753196A patent/JP3756950B2/ja not_active Expired - Fee Related
- 1995-08-09 MX MX9700833A patent/MX9700833A/es unknown
- 1995-08-09 CA CA2196570A patent/CA2196570C/en not_active Expired - Lifetime
- 1995-08-09 EP EP06026820A patent/EP1801204B1/de not_active Expired - Lifetime
- 1995-08-09 EP EP95930814A patent/EP0776361B1/de not_active Expired - Lifetime
- 1995-08-09 AT AT06026820T patent/ATE498006T1/de not_active IP Right Cessation
- 1995-08-09 WO PCT/US1995/010245 patent/WO1996005291A1/en active IP Right Grant
-
2005
- 2005-09-21 JP JP2005274301A patent/JP4339835B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ATE498006T1 (de) | 2011-02-15 |
MX9700833A (es) | 1997-06-28 |
JP3756950B2 (ja) | 2006-03-22 |
DE69535359T2 (de) | 2007-10-11 |
EP0776361A4 (de) | 2003-06-04 |
DK0776361T3 (da) | 2007-04-30 |
CA2196570C (en) | 2010-10-12 |
AU711815B2 (en) | 1999-10-21 |
ES2278382T3 (es) | 2007-08-01 |
EP0776361B1 (de) | 2007-01-03 |
CA2196570A1 (en) | 1996-02-22 |
DE69536138D1 (de) | 2011-03-24 |
AU3405395A (en) | 1996-03-07 |
JPH10506782A (ja) | 1998-07-07 |
DE69535359D1 (de) | 2007-02-15 |
EP0776361A1 (de) | 1997-06-04 |
EP1801204A1 (de) | 2007-06-27 |
JP4339835B2 (ja) | 2009-10-07 |
JP2006055171A (ja) | 2006-03-02 |
US5965138A (en) | 1999-10-12 |
AU711815C (en) | 2003-02-20 |
WO1996005291A1 (en) | 1996-02-22 |
EP1801204B1 (de) | 2011-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE350467T1 (de) | Rekombinantes herpesvirus aus trufhähnen und seine verwendungen | |
CA2196555A1 (en) | Vr-2332 viral nucleotide sequence and methods of use | |
ES8500322A1 (es) | Un metodo de modificar un virus para conferirle una nueva funcion biologica. | |
CA2660355A1 (en) | Polynucleotide vaccine formulation against pathologies of the horse | |
PH25776A (en) | Pseudorabies virus mutants incapable of producing glycoprotein x | |
EE04753B1 (et) | Rekombinantne MVA viirus ja selle kasutamine, isoleeritud eukarüootne rakk, meetod rekombinantse hTyr-proteiini valmistamiseks ning vaktsiin | |
HK1024931A1 (en) | Recombinant swinepox virus | |
EP0210931B1 (de) | Impfstoff gegen Varicella-zoster-Virus | |
DE3853139D1 (de) | Rekombinanter, fremde gene enthaltender menschlicher cytomegalovirus und seine verwendung. | |
EP0294469A4 (de) | Impfstoffe und diagnosetest für haemophilus influenzae. | |
US4999296A (en) | Thymidine kinase negative insertion mutants of pseudorabies virus and methods for the production of same | |
HUP9901005A2 (hu) | Herpeszvírusok RFHV/KSHV-alcsaládjába tartozó vírusokból származó glikoprotein-B | |
DE69929530D1 (de) | Attenuierte pferdeherpesvirus | |
DE69332264D1 (de) | Mutanten des infektiösen rinder rhinotracheitis-virus und impfstoffe | |
EP0256677A3 (de) | Pseudorabiesvirus-Rekombinanten und ihre Verwendung zur Herstellung von Proteinen | |
AU3379693A (en) | Vaccines and diagnostic assays for haemophilus influenzae | |
WO1997003187A3 (en) | Marek's disease virus genes and their use in vaccines for protection against marek's disease | |
ATE244308T1 (de) | Rekombitante, equine herpesviren | |
DK0606452T3 (da) | Vektorvacciner fra rekombinant katteherpesvirus | |
CA2198743A1 (en) | Feline infectious peritonitis vaccine | |
NZ511168A (en) | Recombinant CELO virus and CELO virus DNA | |
ES2074965A1 (es) | Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen. | |
PT99540A (pt) | Processo para obtencao de virus de herpes recombinantes genes vectores e plasmidios utilizados nesse processo e processo para a preparacao de vacinas a base dos mencionados virus recombinantes | |
MY157873A (en) | Recombinant mva virus, and the use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |